Operating Income (Loss) in USD of IMMUNIC, INC. from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IMMUNIC, INC. quarterly/annual Operating Income (Loss) history and change rate from 2012 to Q3 2025.
  • IMMUNIC, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$26M, a 1.04% decline year-over-year.
  • IMMUNIC, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$106M, a 10.2% decline year-over-year.
  • IMMUNIC, INC. annual Operating Income (Loss) for 2024 was -$98.1M, a 1.18% increase from 2023.
  • IMMUNIC, INC. annual Operating Income (Loss) for 2023 was -$99.2M, a 17% increase from 2022.
  • IMMUNIC, INC. annual Operating Income (Loss) for 2022 was -$119M, a 30.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

IMMUNIC, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$106M -$26M -$267K -1.04% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$105M -$27.1M -$4.27M -18.7% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$101M -$26.8M -$2.94M -12.3% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$98.1M -$25.6M -$2.25M -9.62% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 -$95.8M -$25.7M -$2.16M -9.15% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$93.6M -$22.8M +$2.21M +8.82% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$95.9M -$23.9M +$3.37M +12.4% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$99.2M -$23.4M +$33.9M +59.2% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 -$133M -$23.6M -$3.45M -17.2% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$130M -$25M -$4.41M -21.4% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$125M -$27.3M -$5.82M -27.1% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 -$119M -$57.3M -$35.6M -164% 01 Oct 2022 31 Dec 2022 10-K 22 Feb 2024
Q3 2022 -$83.9M -$20.1M -$1.73M -9.4% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$82.2M -$20.6M -$1.44M -7.51% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 -$80.7M -$21.4M +$11M +33.8% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$91.7M -$21.7M -$7.53M -53.1% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 -$84.1M -$18.4M -$4.84M -35.7% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 -$79.3M -$19.2M -$6.95M -56.8% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 -$72.3M -$32.4M -$23.4M -259% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$49M -$14.2M -$6M -73.3% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 -$43M -$13.5M -$4.37M -47.6% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$38.6M -$12.2M +$2.79M +18.6% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 -$41.4M -$9.01M -$4.35M -93.4% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 -$37M -$8.19M -$15.2M -217% 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2021
Q3 2019 -$21.9M -$9.18M -$7.37M -408% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 -$14.5M -$15M -$12.3M -462% 01 Apr 2019 30 Jun 2019 10-Q/A 03 Aug 2020
Q1 2019 -$2.17M -$4.66M +$9.83M +67.8% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q4 2018 -$12M $6.97M +$21.8M 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 -$33.7M -$1.81M +$10.8M +85.7% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019
Q2 2018 -$44.6M -$2.67M +$9.88M +78.7% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 -$54.5M -$14.5M -$1.81M -14.2% 01 Jan 2018 31 Mar 2018 10-Q 10 Apr 2019
Q4 2017 -$52.7M -$14.8M -$2.96M -25% 01 Oct 2017 31 Dec 2017 10-K 04 Mar 2019
Q3 2017 -$49.7M -$12.6M -$2.4M -23.4% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 -$47.3M -$12.5M -$3M -31.5% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018
Q1 2017 -$44.3M -$12.7M -$3.03M -31.4% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q4 2016 -$41.3M -$11.8M -$1.94M -19.6% 01 Oct 2016 31 Dec 2016 10-K 04 Mar 2019
Q3 2016 -$39.3M -$10.2M +$2.1M +17% 01 Jul 2016 30 Sep 2016 10-Q 25 Oct 2017
Q2 2016 -$41.4M -$9.55M +$5.53M +36.7% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017
Q1 2016 -$47M -$9.66M +$5.16M +34.8% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$52.1M -$9.89M +$4.13M +29.4% 01 Oct 2015 31 Dec 2015 10-K 13 Mar 2018
Q3 2015 -$56.2M -$12.3M +$475K +3.71% 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016
Q2 2015 -$56.7M -$15.1M -$3.44M -29.6% 01 Apr 2015 30 Jun 2015 10-Q 02 Aug 2016
Q1 2015 -$53.3M -$14.8M -$2.94M -24.8% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 -$50.3M -$14M -$3.77M -36.8% 01 Oct 2014 31 Dec 2014 10-K 07 Mar 2017
Q3 2014 -$46.6M -$12.8M -$3.65M -39.8% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 -$42.9M -$11.6M -$4.58M -64.8% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015
Q1 2014 -$38.4M -$11.9M -$6.95M -141% 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015
Q4 2013 -$31.4M -$10.2M 01 Oct 2013 31 Dec 2013 10-K 08 Mar 2016
Q3 2013 -$9.17M 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$7.06M 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014
Q1 2013 -$4.93M 01 Jan 2013 31 Mar 2013 10-Q 28 May 2014

IMMUNIC, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$98.1M +$1.17M +1.18% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 -$99.2M +$20.3M +17% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$119M -$27.8M -30.4% 01 Jan 2022 31 Dec 2022 10-K 22 Feb 2024
2021 -$91.7M -$42.7M -87.2% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
2020 -$49M -$11.9M -32.2% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022
2019 -$37M -$25M -209% 01 Jan 2019 31 Dec 2019 10-K 26 Feb 2021
2018 -$12M +$40.7M +77.2% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020
2017 -$52.7M -$11.4M -27.6% 01 Jan 2017 31 Dec 2017 10-K 04 Mar 2019
2016 -$41.3M +$10.9M +20.8% 01 Jan 2016 31 Dec 2016 10-K 04 Mar 2019
2015 -$52.1M -$1.78M -3.53% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018
2014 -$50.3M -$18.9M -60.3% 01 Jan 2014 31 Dec 2014 10-K 07 Mar 2017
2013 -$31.4M -$21.8M -228% 01 Jan 2013 31 Dec 2013 10-K 08 Mar 2016
2012 -$9.58M 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.